Ulinastatin activates the renin-angiotensin system to ameliorate the pathophysiology of severe acute pancreatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1328-1337

  Liu, Ruixia ^a   Qi, Haiyu ^a   Wang, Jing ^a   Wang, Yan ^a   Cui, Lijian ^a   Wen, Yan ^a   Yin, Chenghong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Renin angiotensin system; Severe acute pancreatitis; Ulinastatin

Indexed keywords

AMYLASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; INTERLEUKIN 10; INTERLEUKIN 1BETA; MAS RECEPTOR; MESSENGER RNA; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); CERULETIDE; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOPROTEIN; LIPOPOLYSACCHARIDE; PEPTIDE FRAGMENT;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELISA KIT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; THERAPY EFFECT; UPREGULATION; WESTERN BLOTTING; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PANCREATITIS; PHYSIOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; CERULETIDE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLYCOPROTEINS; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; PANCREATITIS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROSPECTIVE STUDIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SEVERITY OF ILLNESS INDEX;

EID: 84900542844     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12584     Document Type: Article

References (41)

1. Chen S, Shi H, Zou X, Luo H. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp. Pancreas 2010; 39: 1231-1237.
2. Tsujino T, Isayama H, Nakai Y etal. The results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial. J. Gastroenterol. 2013; 48: 982-988.
3. Seta T, Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest. Endosc. 2011; 73: 700-706.e1-2.
4. Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann. Surg. 2006; 243: 154-168.
5. Yoo JW, Ryu JK, Lee SH etal. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas 2008; 37: 366-370.
6. Fujishiro H, Adachi K, Imaoka T etal. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J. Gastroenterol. Hepatol. 2006; 21: 1065-1069.
7. Ueki T, Otani K, Kawamoto K etal. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J. Gastroenterol. 2007; 42: 161-167.
8. Hou J, Zhu MW, He XW, Wei JM, Li YG, Tang DN. Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis. Can. J. Surg. 2010; 53: 241-245.
9. Ma T, Kang C, Shao H, Qi Q, Hu W. Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis. Eur. Surg. Res. 2006; 38: 445-450.
10. Zhang W, Gao J, Zhao T etal. Proteinase-activated receptor 2 mediates thermal hyperalgesia and is upregulated in a rat model of chronic pancreatitis. Pancreas 2011; 40: 300-307.
11. Jo YJ, Choi HS, Jun DW etal. The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats. Int. Immunopharmacol. 2008; 8: 959-966.
12. Jun G, Zhi-jun T, Bao-liang Q, Fei L, Jia-bang S. Significance of trypsinogen activation peptides and interleukin-6 in experimental acute pancreatitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011; 33: 205-209.
13. Tani T, Abe H, Endo Y, Hanasawa K, Kodama M. Effects of a urinary trypsin inhibitor on acute circulatory insufficiency after surgical operation. Am. J. Surg. 1998; 175: 142-145.
14. Chan YC, Leung PS. Co-operative effects of angiotensin II and caerulein in NFkappaB activation in pancreatic acinar cells in vitro. Regul. Pept. 2011; 166: 128-134.
15. Chan YC, Leung PS. The renin-angiotensin system and reactive oxygen species: implications in pancreatitis. Antioxid. Redox Signal. 2011; 15: 2743-2755.
16. Oruc N, Ozutemiz O, Nart D, Yuce G, Celik HA, Ilter T. Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target. Exp. Toxicol. Pathol. 2010; 62: 353-360.
17. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J. Gastroenterol. 2008; 43: 823-832.
18. Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem. Pharmacol. 2008; 75: 781-786.
19. Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the rennin-angiotensin system. J. Endocrinol. 2012; 216: R1-R17.
20. Wang Y, Wang J, Liu R etal. Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7). Pancreatology 2012; 12: 451-457.
21. Ding SP, Li JC, Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J. Gastroenterol. 2003; 9: 584-589.
22. Jaworek J, Jachimczak B, Tomaszewska R etal. Protective action of lipopolysaccharidesin rat caerulein-induced pancreatitis: role of nitric oxide. Digestion 2000; 62: 1-13.
23. Schmidt J, Lewandrowsi K, Warshaw AL, Compton CC, Rattner DW. Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat. Int. J. Pancreatol. 1992; 12: 41-51.
24. Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42: 886-891.
25. Chappell MC, Millsted A, Diz DI, Brosnihan KB, Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J. Hypertens. 1991; 9: 751-759.
26. Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 2006; 86: 747-803.
27. Ramracheya RD, Muller DS, Wu Y etal. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 2006; 49: 321-331.
28. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin-angiotensin system in human pancreas. J. Endocrinol. 1999; 161: 317-322.
29. Lam KY, Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur. J. Endocrinol. 2002; 146: 567-572.
30. Liu WB, Wang XP, Wu K, Zhang RL. Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J. Gastroenterol. 2005; 11: 6489-6494.
31. Lupi R, Del GS, Bugliani M etal. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur. J. Endocrinol. 2006; 154: 355-361.
32. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 2006; 20: 953-970.
33. Tsang SW, Cheng CH, Leung PS. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul. Pept. 2004; 119: 213-219.
34. Escobar J, Pereda J, Arduini A etal. Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinol. Biochem. Pharmacol. 2012; 83: 122-130.
35. Booth DM, Murphy JA, Mukherjee R etal. Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells. Gastroenterology 2011; 140: 2116-2125.
36. Fang HJ, Yang JK. Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas. J. Int. Med. Res. 2010; 38: 558-569.
37. Passos-Silva DG, Verano-Braga T, Santos RA. Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. (Lond.) 2013; 124: 443-456.
38. Al-Maghrebi M, Benter IF, Diz DI. Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats. Pharmacol. Res. 2009; 59: 263-268.
39. Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R, Campagnole-Santos MJ. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin. Investig. Drugs 2005; 14: 1019-1031.
40. Chappell MC. Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation. Arthritis Res. Ther. 2010; 12: 128.
41. Hanafy S, Tavasoli M, Jamali F. Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart. Inflammation 2011; 34: 609-613.